Cancer Research3d
Abstract A077: Estrogen-responsive fractions drive the immunosuppressive tumor microenvironment and immunotherapy resistance
1Seoul National University, Seoul, Korea, Republic of.
Cancer Research3d
Abstract A102: Assessment of CIT-drugs MoA with in vivo and 3D in vitro imaging
Cancer Immunotherapies (CITs) have shown unprecedented results in improving tumor control. However, many patients are still refractory to treatment. A deeper understanding of CIT-drugs mode of action ...
Cancer Research3d
Abstract A107: Updated results from a study of evalstotug (BA3071), an anti–CTLA-4 conditionally active biologic, in melanoma
Search for other works by this author on: ...
Cancer Research13d
The Germline and Somatic Origins of Prostate Cancer Heterogeneity
Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license Newly ...
Cancer Research3d
Abstract A066: Enhancing breast cancer immunotherapy by modulating the cGAS–STING and CEACAM1–TIM3 pathways in the tumor microenvironment
Immune checkpoint blockade (ICB) therapy has revolutionized cancer treatment, delivering impressive results across various cancers. However, resistance is common, and only a limited number of patients ...
Cancer Research5d
Investigators Note Hazards of Cutting NIH Indirect Costs
The NIH recently announced a cap of 15% on indirect costs for new grants. This plan has been temporarily blocked in federal court with a hearing scheduled for February 21. If cuts are implemented, ...
Cancer Research6d
CDC Vaccine Meeting, First Under RFK Jr.’s Tenure, Postponed
A Centers for Disease Control and Prevention (CDC) meeting on vaccines originally scheduled for next week has been postponed, according to a senior official from the Department of Health and Human ...
Cancer Research12d
Antitumor CD4+ T helper 1 cells target and control the outgrowth of disseminated cancer cells
Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...
Cancer Research1d
Special Series: Driving Cancer Discoveries with Computational Research, Data Science, and Machine Learning/AI
Publishing in July 2025 to coincide with the AACR Special Conference in Cancer Research: Artificial Intelligence and Machine Learning, the series will continue through December 2025! Technological ...
Cancer Research8d
CAR T Cells Can Arm Other Immune Cells By “Nibbling” Them
Research shows that chimeric antigen receptor (CAR) T cells can endow other immune cells with their cancer-killing abilities through trogocytosis, the exchange of cell-surface proteins with ...
Cancer Research12d
Fred Hutch Ends DEI Programs
Fred Hutch Cancer Center in Seattle, WA, terminated its diversity, equity, and inclusion (DEI) initiatives due to President Donald Trump’s executive order threatening to withhold funding to federal ...
Cancer Research8d
Woman Remains Cancer-Free 18-Plus Years After CAR T-Cell Therapy
A woman who received chimeric antigen receptor (CAR) T-cell therapy for neuroblastoma as a girl in 2006 is in complete remission more than 18 years later, according to a long-term follow up report ...